Successful Webinar “Management of autonomic dysfunction” – July 2021
Successful Webinar “Early management of diabetes & microvascular complications” – April 2021
SUDOSCAN in wild-type cardiac amyloidosis and AA amyloidosis – JFMA 2020
Successful web conference 2020 on SUDOSCAN utility in diabetes
EASD 2019 poster: diabetic foot risk detection with SUDOSCAN
Conference of WoundHSI 2019 SUDOSCAN presentation
Information for US Customers:
Our dedicated US website is now available at us.sudoscan.com. Feel free to visit it for local product information and support.
About Sudoscan
Sudoscan is a class IIa Medical device, Manufactured by Impeto Medical, indicated for early identification and follow-up of peripheral autonomic neuropathies.
For professional use only, read instructions before use. This medical device is a regulated health product which bears, under this regulation, the CE mark
Sudoscan in the world
More information
Contact info
Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
